Associate, Educational Strategy | Cardiology, Endocrinology, and Nephrology | Youth Soccer Coach
In the world of youth sports, being diagnosed with asthma of any kind serves as a massive roadblock. As someone who has lived through this as a teen, I understand how living with this condition can hinder a child's ability to develop as an athlete and more importantly, prevent them from playing the sports they love. It's great to hear that the FDA has approved this expanded indication for children with severe asthma, and it's an even better thing to know that companies like AstraZeneca are working towards improving the quality of life of youth athletes with this condition. #FDAapproval #severeasthma #pediatrics
We are pleased to share that the US FDA has approved an additional indication for an add-on maintenance treatment for children aged 6 to 11 living with severe eosinophilic asthma. Read more about this regulatory milestone and our dedication to delivering expanded solutions to support asthma patients by addressing critical healthcare needs:?bit.ly/3JeLz7j #AZUS This content is for U.S. audiences only.
